about
Genetic variation in SCN10A influences cardiac conductionA large-scale evaluation of computational protein function prediction3DLigandSite: predicting ligand-binding sites using similar structuresAn expanded evaluation of protein function prediction methods shows an improvement in accuracyTen simple rules for a community computational challengeThe Phyre2 web portal for protein modeling, prediction and analysisRisks Posed by Reston, the Forgotten Ebolavirus.Computational analysis of Ebolavirus data: prospects, promises and challenges.Prediction of ligand binding sites using homologous structures and conservation at CASP8.Genetic loci influencing kidney function and chronic kidney diseaseProteomic analysis of the Plasmodium male gamete reveals the key role for glycolysis in flagellar motility.The flagellum in malarial parasites.Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.CombFunc: predicting protein function using heterogeneous data sourcesTowards the prediction of protein interaction partners using physical dockingThe South Asian genome.Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels.Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls.Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-ASChanges associated with Ebola virus adaptation to novel species.Conserved differences in protein sequence determine the human pathogenicity of Ebolaviruses.Challenges for the prediction of macromolecular interactions.ConFunc--functional annotation in the twilight zone.Associating mutations causing cystinuria with disease severity with the aim of providing precision medicine.Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance.Identification of flubendazole as potential anti-neuroblastoma compound in a large cell line screen.Investigating Ebola virus pathogenicity using molecular dynamics.Convergent evolution of enzyme active sites is not a rare phenomenon.Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transportVarMod: modelling the functional effects of non-synonymous variants.The automated function prediction SIG looks back at 2013 and prepares for 2014.Desulfovibrio vulgaris CbiKP cobaltochelatase: evolution of a haem binding protein orchestrated by the incorporation of two histidine residues.Protein-protein interaction sites are hot spots for disease-associated nonsynonymous SNPs.The genetic diversity of cystinuria in a UK population of patients.The Role of Protein Modelling in Predicting the Disease Severity of CystinuriaUnderstanding of researcher behavior is required to improve data reliabilityIs the Bombali virus pathogenic in humans?Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to CisplatinDoxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cellsTesting of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
P50
Q24294598-74BB17D3-33AB-4D3E-AA3F-E4E2F6220736Q24614831-2913D7B1-DD3D-4302-9B6F-C7FF760A20DBQ24621635-C4797CE0-B9FF-4275-B90D-8A48A992D480Q28596092-896E56A4-DE80-4AE2-A801-C972D281C8CDQ28974681-DC111A96-F65A-4CFE-8CF2-DBDDD830A2CDQ29616136-09F060D9-D2A6-4F34-906C-3A256DF615F3Q30239113-7A29ECA5-D778-41B1-9E7B-7E4E06646420Q30248476-F0B29725-BA68-4F6A-864D-4BBB4E080069Q30379193-53D6ECB0-6B9B-480F-A6AD-8012BBC35D85Q34109552-92BABDD1-E809-4C31-B7F7-00B96C633AC4Q34116343-8923DE44-05E7-4172-9C11-A8304673FE2BQ34121923-B4DD525A-97A6-4EB7-A485-C14CF8571119Q34224637-0B0952AD-5F5B-4875-A3E0-B02D60DA85D0Q34284958-C4653882-6109-4B62-8D8F-3EF9AC6EC198Q34715175-A0BF15D9-DE58-4EAB-A606-93952F267CFAQ35223424-86063BA9-88C9-4A07-B231-B1AC6A16615BQ35226441-8C50941F-B231-4976-A447-AEB0A5E8FDA5Q36159362-CC3E223B-0C6C-4284-A85F-102E5ECADC1BQ36278738-910A9997-0E6D-4DAE-9E86-06A1CB213396Q36281532-D276B037-954F-4EE5-910C-35C95A45D51BQ36724747-8F8ACE9F-E706-4A08-876A-E46C6306B4B5Q37865815-F7D9644F-57FB-4D9A-B6AB-638F4B663B93Q38514406-250CFD6B-3289-4F8A-84B9-4A41E1214A13Q38622499-F7F18627-2DF1-483E-8617-5351CD51C639Q38741378-AFE3BB2D-02EB-411C-B4AB-51E255C3ABE5Q38913917-72B4D309-4ACB-40DC-AD15-B36E31398D7CQ40043173-9800E657-FE64-41F4-98B3-84D39CC90878Q41447676-EC04E314-C8B5-470E-81B5-3C6F4F7F3B80Q41975402-BF3A2082-5226-4E52-98F4-4CC04130E6ADQ42024924-52B3994B-B2C3-4AAE-8A24-569AB38D72B3Q42719524-9C7C09A1-5CAC-4666-B9AA-032610F036D1Q46506915-E0A1A50E-6DE2-48C8-9DE6-20A4EB02313FQ52618147-8729745F-D1AD-4A07-848E-33BFDA52AA55Q54195283-26C7A922-7B99-41F2-8BCE-0A8EDA93187AQ61912490-394E248A-7E81-48FE-8AE3-298F6C47421DQ64272799-6D34F6C7-A97C-4484-ABEB-6678C7B0977DQ64359308-DADBB6E4-5E23-44D7-8388-37B07D3AC9A5Q89896518-214BD67F-2367-4BFF-8602-57F3165127B3Q90004944-667E1770-53FD-4B09-A9EF-E8FFDA2D9891Q90047188-7BCE4DA0-7870-45DD-8A47-E37F5C898195
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mark N Wass
@nl
Mark N Wass
@sl
Mark N. Wass
@en
Mark N. Wass
@es
type
label
Mark N Wass
@nl
Mark N Wass
@sl
Mark N. Wass
@en
Mark N. Wass
@es
altLabel
Mark N Wass
@en
prefLabel
Mark N Wass
@nl
Mark N Wass
@sl
Mark N. Wass
@en
Mark N. Wass
@es
P106
P1153
20435115000
P21
P2456
P31
P496
0000-0001-5428-6479